Reaction Details Report a problem with these data
Target
Galactokinase
Ligand
BDBM249779
Substrate
n/a
Meas. Tech.
qHTS Assay
IC50
4212.9±n/a nM
Citation
 Boxer, MB; Walsh, MJ; Liu, L; Tanega, CD; Shen, M; Lai, K; Tang, M; Auld, DS Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders US Patent  US9447087 Publication Date 9/20/2016 
Target
Name:
Galactokinase
Synonyms:
GALK | GALK1 | GALK1_HUMAN | Galactokinase | Galactokinase (GALK) | Galactose kinase
Type:
Enzyme
Mol. Mass.:
42271.26
Organism:
Homo sapiens (Human)
Description:
P51570
Residue:
392
Sequence:
MAALRQPQVAELLAEARRAFREEFGAEPELAVSAPGRVNLIGEHTDYNQGLVLPMALELMTVLVGSPRKDGLVSLLTTSEGADEPQRLQFPLPTAQRSLEPGTPRWANYVKGVIQYYPAAPLPGFSAVVVSSVPLGGGLSSSASLEVATYTFLQQLCPDSGTIAARAQVCQQAEHSFAGMPCGIMDQFISLMGQKGHALLIDCRSLETSLVPLSDPKLAVLITNSNVRHSLASSEYPVRRRQCEEVARALGKESLREVQLEELEAARDLVSKEGFRRARHVVGEIRRTAQAAAALRRGDYRAFGRLMVESHRSLRDDYEVSCPELDQLVEAALAVPGVYGSRMTGGGFGGCTVTLLEASAAPHAMRHIQEHYGGTATFYLSQAADGAKVLCL
  
Inhibitor
Name:
BDBM249779
Synonyms:
US9447087, 4
Type:
Small organic molecule
Emp. Form.:
C19H20N4O2
Mol. Mass.:
336.3877
SMILES:
O=C1CCCC2=C1C1(CCCC1)N=C(Nc1nc3ccccc3o1)N2 |c:5,t:14|
Structure:
Search PDB for entries with ligand similarity: